相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Emerging drugs for treatment of anemia of chronic kidney disease
Jametta S. Magwood et al.
EXPERT OPINION ON EMERGING DRUGS (2013)
Peginesatide as a new approach for treating anemia of CKD patient: is it like a falling star?
Francesco Locatelli et al.
EXPERT OPINION ON PHARMACOTHERAPY (2013)
A Low-Molecular-Weight Compound K7174 Represses Hepcidin: Possible Therapeutic Strategy against Anemia of Chronic Disease
Tohru Fujiwara et al.
PLOS ONE (2013)
Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation
Chia Chi Sun et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
New Anemia Therapies: Translating Novel Strategies From Bench to Bedside
Iain C. Macdougall
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis
Anu Laitala et al.
BLOOD (2012)
Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis
Simon Beuck et al.
DRUG TESTING AND ANALYSIS (2012)
Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia
Barbra J. Sasu et al.
BLOOD (2010)
Hepcidin in anemia and inflammation in chronic kidney disease
Jolanta Malyszko et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2007)
Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure
Wanja M. Bernhardt et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases
K Hirota et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Pure red-cell aplasia and epoetin therapy
CL Bennett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
分享论文
